Accelerating breast MRI acquisition with generative AI models.

OBJECTIVES: To investigate the use of the score-based diffusion model to accelerate breast MRI reconstruction. MATERIALS AND METHODS: We trained a score-based model on 9549 MRI examinations of the female breast and employed it to reconstruct undersampled MRI images with undersampling factors of 2, 5, and 20. Images were evaluated by two experienced radiologists who rated the images based on their overall quality and diagnostic value on an independent test set of 100 additional MRI examinations. RESULTS: The score-based model produces MRI images of high quality and diagnostic value. Both T1- and T2-weighted MRI images could be reconstructed to a high degree of accuracy. Two radiologists rated the images as almost indistinguishable from the original images (rating 4 or 5 on a scale of 5) in 100% (radiologist 1) and 99% (radiologist 2) of cases when the acceleration factor was 2. This fraction dropped to 88% and 70% for an acceleration factor of 5 and to 5% and 21% with an extreme acceleration factor of 20. CONCLUSION: Score-based models can reconstruct MRI images at high fidelity, even at comparatively high acceleration factors, but further work on a larger scale of images is needed to ensure that diagnostic quality holds. CLINICAL RELEVANCE STATEMENT: The number of MRI examinations of the breast is expected to rise with MRI screening recommended for women with dense breasts. Accelerated image acquisition methods can help in making this examination more accessible. KEY POINTS: Accelerating breast MRI reconstruction remains a significant challenge in clinical settings. Score-based diffusion models can achieve near-perfect reconstruction for moderate undersampling factors. Faster breast MRI scans with maintained image quality could revolutionize clinic workflows and patient experience.

Fibroglandular tissue segmentation in breast MRI using vision transformers: a multi-institutional evaluation.

Accurate and automatic segmentation of fibroglandular tissue in breast MRI screening is essential for the quantification of breast density and background parenchymal enhancement. In this retrospective study, we developed and evaluated a transformer-based neural network for breast segmentation (TraBS) in multi-institutional MRI data, and compared its performance to the well established convolutional neural network nnUNet. TraBS and nnUNet were trained and tested on 200 internal and 40 external breast MRI examinations using manual segmentations generated by experienced human readers. Segmentation performance was assessed in terms of the Dice score and the average symmetric surface distance. The Dice score for nnUNet was lower than for TraBS on the internal testset (0.909 ± 0.069 versus 0.916 ± 0.067, P < 0.001) and on the external testset (0.824 ± 0.144 versus 0.864 ± 0.081, P = 0.004). Moreover, the average symmetric surface distance was higher (= worse) for nnUNet than for TraBS on the internal (0.657 ± 2.856 versus 0.548 ± 2.195, P = 0.001) and on the external testset (0.727 ± 0.620 versus 0.584 ± 0.413, P = 0.03). Our study demonstrates that transformer-based networks improve the quality of fibroglandular tissue segmentation in breast MRI compared to convolutional-based models like nnUNet. These findings might help to enhance the accuracy of breast density and parenchymal enhancement quantification in breast MRI screening.

A multimodal comparison of latent denoising diffusion probabilistic models and generative adversarial networks for medical image synthesis.

Although generative adversarial networks (GANs) can produce large datasets, their limited diversity and fidelity have been recently addressed by denoising diffusion probabilistic models, which have demonstrated superiority in natural image synthesis. In this study, we introduce Medfusion, a conditional latent DDPM designed for medical image generation, and evaluate its performance against GANs, which currently represent the state-of-the-art. Medfusion was trained and compared with StyleGAN-3 using fundoscopy images from the AIROGS dataset, radiographs from the CheXpert dataset, and histopathology images from the CRCDX dataset. Based on previous studies, Progressively Growing GAN (ProGAN) and Conditional GAN (cGAN) were used as additional baselines on the CheXpert and CRCDX datasets, respectively. Medfusion exceeded GANs in terms of diversity (recall), achieving better scores of 0.40 compared to 0.19 in the AIROGS dataset, 0.41 compared to 0.02 (cGAN) and 0.24 (StyleGAN-3) in the CRMDX dataset, and 0.32 compared to 0.17 (ProGAN) and 0.08 (StyleGAN-3) in the CheXpert dataset. Furthermore, Medfusion exhibited equal or higher fidelity (precision) across all three datasets. Our study shows that Medfusion constitutes a promising alternative to GAN-based models for generating high-quality medical images, leading to improved diversity and less artifacts in the generated images.